Refusal to market new drugs

Other Names:
Refusal to test new drugs
Denial of potential health aids
Stopping development of medical cures
New drugs that can counteract tuberculosis are ready for testing, but the American pharmaceutical industry refuses to pay to test and market them due to the costs involved, which it claims are $200 million US. It says that the US market for the drug is too small to recover its costs, entirely ignoring about 1.75 billion tubercular people outside its borders who need the drugs. There is no American or global agency that can legally force the pharmaceutical companies to sell their products.
Related UN Sustainable Development Goals:
GOAL 1: No PovertyGOAL 2: Zero HungerGOAL 3: Good Health and Well-beingGOAL 4: Quality EducationGOAL 5: Gender EqualityGOAL 6: Clean Water and SanitationGOAL 7: Affordable and Clean EnergyGOAL 8: Decent Work and Economic GrowthGOAL 9: Industry, Innovation and InfrastructureGOAL 10: Reduced InequalityGOAL 11: Sustainable Cities and CommunitiesGOAL 12: Responsible Consumption and ProductionGOAL 13: Climate ActionGOAL 14: Life Below WaterGOAL 15: Life on LandGOAL 16: Peace and Justice Strong InstitutionsGOAL 17: Partnerships to achieve the Goal
Problem Type:
G: Very specific problems
Date of last update
04.10.2020 – 22:48 CEST